The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of sex and adverse events (AEs) of adjuvant chemotherapy (ACT) in early stage colon cancer (CC): A pooled analysis of 28,636 patients (pts) in the ACCENT database.
 
Anna Dorothea Wagner
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Celgene; Lilly; Merck KGaA; Pfizer; Roche/Genentech; SERVIER; Shire
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD Oncology
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme
 
Thierry Andre
Honoraria - AMGEN; Bayer; Bristol-Myers Squibb; PRMA Consulting; Roche/Genentech; Sanofi; SERVIER; Xbiotech
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Guardant Health; HalioDX; MSD Oncology; Mundipharma; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
 
Jesse Dixon
No Relationships to Disclose
 
Norman Wolmark
No Relationships to Disclose
 
Daniel G. Haller
Consulting or Advisory Role - Genentech; Lilly
Speakers' Bureau - Amgen; Genentech/Roche; Taiho Pharmaceutical
Expert Testimony - Celgene
 
Carmen Joseph Allegra
Honoraria - Bristol-Myers Squibb (I)
 
Eric VanCutsem
Research Funding - Amgen; Bayer Schering Pharma; Boehringer Ingelheim; Celgene; Ipsen; Lilly; Merck KGaA; Novartis; Roche Pharma AG; Sanofi; SERVIER
 
Thomas J. George
Consulting or Advisory Role - Bayer; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Pharmacyclics (Inst); Tesaro (Inst)
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Steven R. Alberts
No Relationships to Disclose
 
Chris Twelves
No Relationships to Disclose
 
Michael O'Connell
No Relationships to Disclose
 
Leonard B. Saltz
Consulting or Advisory Role - McNeil PPC (I)
Research Funding - Taiho Pharmaceutical
 
Charles David Blanke
No Relationships to Disclose
 
Guido Francini
No Relationships to Disclose
 
Rachel Kerr
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; kanghong Pharma; Merck; Merck KGaA; Merrimack; Pfizer; Taiho Pharmaceutical; Targovax
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
Greg Yothers
No Relationships to Disclose
 
Qian Shi
No Relationships to Disclose